These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5511639)

  • 21. Blood group antigens in tumor cell membranes.
    Coon JS; Weinstein RS
    Biomembranes; 1983; 11():173-205. PubMed ID: 6338946
    [No Abstract]   [Full Text] [Related]  

  • 22. The study of ABO blood groups and relationship with cancer breast (a preliminary report).
    Majupuria KC; Gupta SR; Gupta LC
    Indian J Cancer; 1966 Sep; 3(3):182-3. PubMed ID: 5917026
    [No Abstract]   [Full Text] [Related]  

  • 23. Histo-blood group antigens as allo- and autoantigens.
    Nydegger UE; Tevaearai H; Berdat P; Rieben R; Carrel T; Mohacsi P; Flegel WA
    Ann N Y Acad Sci; 2005 Jun; 1050():40-51. PubMed ID: 16014519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on blood group Bm from medico-legal aspects. 1. Serological study on group Bm].
    Ishizu H
    Nihon Hoigaku Zasshi; 1968 Nov; 22(6):618-26. PubMed ID: 5753444
    [No Abstract]   [Full Text] [Related]  

  • 25. Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions.
    Rody A; Holtrich U; Solbach C; Kourtis K; von Minckwitz G; Engels K; Kissler S; Gätje R; Karn T; Kaufmann M
    Endocr Relat Cancer; 2005 Dec; 12(4):903-16. PubMed ID: 16322330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphism of ZuBeCa3 microsatellite and its association with mammary tumor in dogs.
    Bhattacharya TK; Rani S; Maiti SK; Dayal S; Kumar P; Sharma A
    Int J Immunogenet; 2007 Jun; 34(3):161-5. PubMed ID: 17504505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetical studies of malignant tumors. I. Genetical studies on breast cancer.
    Nakano K
    Kumamoto Med J; 1967 Jun; 20(2):112-22. PubMed ID: 6074061
    [No Abstract]   [Full Text] [Related]  

  • 28. A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma.
    Sun JM; Han W; Im SA; Kim TY; Park IA; Noh DY; Heo DS; Bang YJ; Choe KJ; Kim NK
    Cancer; 2004 Dec; 101(11):2516-22. PubMed ID: 15517588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current clinical concepts in hemolytic disease and blood group incompatibility.
    Cherry SH
    Prog Clin Biol Res; 1981; 70():205-12. PubMed ID: 6273933
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of blood group serologic findings in suspected ABO-caused erythroblastosis].
    Dahr P
    Med Welt; 1966 Nov; 45():2428-30. PubMed ID: 6009609
    [No Abstract]   [Full Text] [Related]  

  • 31. Case report: diffuse splenic metastasis of occult breast cancer with incompatible blood group antigenic determinants.
    Baranyay F
    Acta Histochem; 2009; 111(4):343-8. PubMed ID: 19201455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on underdeveloped blood group factors].
    Iseki S
    Nihon Hoigaku Zasshi; 1970 May; 24(3):197-8. PubMed ID: 5530691
    [No Abstract]   [Full Text] [Related]  

  • 33. Expression array technology in the diagnosis and treatment of breast cancer.
    Jeffrey SS; Fero MJ; Børresen-Dale AL; Botstein D
    Mol Interv; 2002 Apr; 2(2):101-9. PubMed ID: 14993355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [ABO blood group typing in forensic autopsies].
    Nishi K
    Nihon Hoigaku Zasshi; 2005 Oct; 59(2):111-7. PubMed ID: 16296382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tumors and heredity].
    Azzini N
    Minerva Med; 1972 Dec; 63(86):4715-7. PubMed ID: 4642654
    [No Abstract]   [Full Text] [Related]  

  • 36. Expression of HER2/neu in primary and metastatic breast cancer.
    Tuziak T; Olszewski WP; Olszewski W; Pieńkowski T
    Pol J Pathol; 2001; 52(1-2):21-6. PubMed ID: 11505677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
    Skovlund VR
    APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible linkage of a breast cancer-susceptibility locus to the ABO locus: sensitivity of LOD scores to a single new recombinant observation.
    Skolnick MH; Thompson EA; Bishop DT; Cannon LA
    Genet Epidemiol; 1984; 1(4):363-73. PubMed ID: 6544244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
    Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A
    Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of some inherited blood characters, changes in fifth fraction of serum lactate dehydrogenase, and resistance to cytembena in women with gynaecological carcinoma.
    Milunicová A; Jandová A; Skoda V
    Neoplasma; 1971; 18(2):219-24. PubMed ID: 5577318
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.